VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q1 2024

SEC EDGAR SourceSEC Filings

Top Holdings7 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TLTTLT
ETF

ISHARES 20 PLUS YEAR TREASURY BD

2.5M$234M38.7%$91.28-6.57%
8 qtrssince 2022-Q2
Unchanged
0
AGGAGG
ETF

ISHARES TR

1.7M$166.3M27.5%$92.65-3.73%
16 qtrssince 2020-Q2
Unchanged
0
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

284,690$149.7M24.8%$394.73+30.14%
16 qtrssince 2020-Q2
Decreased
0
VUGVUG
ETF

VANGUARD GROWTH ETF

95,790$33M5.5%$34.94+62.49%
7 qtrssince 2022-Q3
Decreased
0
IWFIWF
ETF

ISHARES TR RUSSELL 1000 GROWTH INDEX FUND

39,315$13.3M2.2%$248.00+34.87%
7 qtrssince 2022-Q3
Decreased
0
VTVVTV
ETF

VANGUARD VALUE ETF

36,300$5.9M1.0%$121.52+28.90%
8 qtrssince 2022-Q2
Unchanged
0
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

12,300$2.2M0.4%$143.37+20.93%
8 qtrssince 2022-Q2
Decreased
0
$604.4M
AUM
7
Positions
Q1 2024
Filing
Rating · 1.5
Quarterly Portfolio Change
+4%Q4'22$573.1M+5%Q1'23$600.2M+10%Q2'23$660.4M-7%Q3'23$613.3M+22%Q4'23$749.8M-19%Q1'24$604.4M
Activity profile
$ moved · Q1'24
New0%Increased0%Decreased84%Exited16%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q0%1-4Q0%1-2Y57%2Y+43%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $604.4M across 7 positions as of Q1 2024. Top holdings: TLT (38.7%), AGG (27.5%), IVV (24.8%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 1.5/5.0.

Q1 2024 Summary

Exited 2, trimmed 4. No standout high-conviction moves this quarter. Portfolio: $604M across 7 positions.

Top holdings by portfolio weight

Total AUM$604M
TLT38.73%
AGG27.52%
IVV24.76%
VUG5.46%
IWF2.19%
VTV0.98%
IWD0.36%
IJH0.00%
IWR0.00%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record85
Conviction49
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVANGUARD GROWTH ETF
Q3 2025 Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQ
Q4 2025 Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVANGUARD FTSE EMERGING MARKETS
Q1 2026 Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used